1-SA/A

AMENDMENT NO. 1

Company: Alzamend Neuro, Inc.
Filed: August 28, 2020
Period of Report: October 31, 2019
Accession Number: 0001214659-20-007533

View Document ↗ View on SEC.gov ↗